Cardiology – Page 7 – Clinical Trial Results

Dr. Daniel Gaudet and Dr. C. Michael Gibson Discuss: Plozasiran (ARO-APOC3), An Investigational RNAi Therapeutic, Demonstrates Profound And Durable Reductions In APOC-3 And Triglycerides (TG) In Patients With Severe Hypertriglyceridemia (SHTG), SHASTA-2 Final Results

April 7, 2024

Disclosures: TBD

Dr. Brian Bergmark and Dr. C. Michael Gibson Discuss: Efficacy And Safety Of Olezarsen In Patients With Hypertriglyceridemia And High Cardiovascular Risk: Primary Results Of The BRIDGE-TIMI 73a Trial

April 7, 2024

Disclosures: https://disclosures.acc.org/Public/AnnualMeetingAppConsol?pid=21006

Dr. Alexander Fanaroff and Dr. C. Michael Gibson Discuss: Effect Of Gamification, Financial Incentives Or Both Combined To Increase Physical Activity Among Patients With Elevated Risk For Major Adverse Cardiovascular Events. The Be Active Randomized Clinical Trial

April 7, 2024

Disclosures: TBD

Dr. C. Michael Gibson and Dr. Serge Korjian Discuss: CSL112 (Apolipoprotein A-I) Infusions And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results

April 6, 2024

Disclosures: TBD

Dr. Javed Butler and Dr. C. Michael Gibson Discuss: Empagliflozin After Acute Myocardial Infarction: Results Of The EMPACT-MI Trial

April 6, 2024

Disclosures: TBD

Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: A Double-blind, Randomized Placebo Procedure-controlled Trial Of An Interatrial Shunt In Patients With HfrEF And HfpEF: Principal Results From The RELIEVE-HF Trial

April 6, 2024

Disclosures: TBD

Dr. Robert Yeh and Dr. C. Michael Gibson Present: AGENT IDE Trial Results

April 3, 2024

Disclosures: TBD

Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial.

February 14, 2024

Disclosures: s/b HeartFlow

Dr. DJ Lakkireddy and Dr. C Michael Gibson present: newest clinical guidelines released for preventing and optimally managing atrial fibrillation

February 12, 2024

Disclosures: TBD

Dr. Pam Taub and Dr. C. Michael Gibson Present: Prevention and Cardiometabolic Disease 2023 Year in Review

January 4, 2024

Disclosures: TBD